The Evolution of Incretins - A Revolution in Diabetes Management?

The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: www.medscape.org/viewarticle/...